T-CELL LYMPHOMA
Clinical trials for T-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new T-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Drug trial tests treatment for rare skin cancer
Disease control CompletedThis study tested brentuximab vedotin in Chinese adults with CD30-positive cutaneous T-cell lymphoma, a rare type of skin cancer. Ten participants received the drug through an IV every 3 weeks for up to 16 cycles. Researchers monitored how well the treatment worked and tracked si…
Matched conditions: T-CELL LYMPHOMA
Phase: PHASE4 • Sponsor: Takeda • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New drug combo tested for Tough-to-Treat blood cancers
Disease control CompletedThis early-stage study tested a new drug called PRT2527, both by itself and combined with other cancer drugs, in people with advanced blood cancers that had returned or stopped responding to standard treatments. The main goals were to find a safe dose and see if the treatments sh…
Matched conditions: T-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: Prelude Therapeutics • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for lymphoma patients after chemo fails
Disease control CompletedThis study tested whether the drug brentuximab vedotin could help control T-cell lymphoma that had returned or stopped responding to previous chemotherapy. The trial enrolled 23 patients whose cancer cells had low levels of a specific target called CD30. Researchers wanted to see…
Matched conditions: T-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Deepa Jagadeesh • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC